MKI67 and neoplasm: Hematoxylin and eosin (H&E) stained sections indicated a more conspicuous tumor necrotic region in the combination therapy group, whereas immunohistochemistry revealed decreased Ki-67 expression in the combination therapy group, signifying reduced tumor proliferation capability (Figure 5E).